FULL SUPPLEMENT: The New Landscape of Field Cancerization: Proven Efficacy Without Severe Skin Reactions

July 2025 | Volume 24 | Issue 7 | 19911s1 | Copyright © July 2025


Published online June 30, 2025

ET AL

Abstract
Actinic keratosis (AK) is a precancerous lesion that occurs with greatest frequency in individuals aged 60 or older and in men. Given the role of chronic UV exposure in engendering these lesions, they are more commonly found on sun-exposed areas such as the face, ears, scalp, hands, and arms.
In this issue:

Tirbanibulin 1% Ointment: Clinical Trial and Real-World Evidence on Efficacy, Tolerability, Safety, and Patient-Reported Outcomes
Actinic keratosis (AK) is a skin lesion that arises due to chronic sun exposure. Treatment of all AKs is recommended due to their risk of progressing to squamous cell carcinomas (SCCs). 
Read more

Tirbanibulin 1% Ointment: The Mechanism of Action of a Novel Topical Therapy for Actinic Keratosis
Actinic keratosis (AK) is a common, precancerous skin lesion that may progress to squamous cell carcinoma (SCC). Traditional topical therapies for AKs often require long treatment durations.
Read more
Close Menu